Effect of ICU interventions on gastrointestinal motility

被引:23
作者
Fruhwald, Sonja [1 ]
Kainz, Johann [1 ]
机构
[1] Med Univ Graz, Div Anesthesiol Cardiovasc Surg & Intens Care Med, Dept Anesthesiol & Intens Care Med, A-8036 Graz, Austria
关键词
enteral nutrition; gastrointestinal motility; gastroparesis; ICU; microbiota; opioid antagonists; CRITICALLY-ILL PATIENTS; BACTERIAL OVERGROWTH; INTRAVENOUS LIDOCAINE; POSTOPERATIVE ILEUS; DOUBLE-BLIND; PRUCALOPRIDE; ALVIMOPAN; CONSTIPATION; ANTAGONISTS; MECHANISMS;
D O I
10.1097/MCC.0b013e3283356679
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Purpose of review Early detection of gastrointestinal motility disturbances is a major goal to reduce the incidence of this potentially disastrous event by prophylactic managements and early goal-directed therapy in patients at risk. Recent findings Gastroparesis frequently results in the inability to feed critically ill patients, aggravating problems such as bacterial translocation and stress-induced intestinal damage. Recently published data have advanced our understanding of the pathophysiologic background of gastroparesis, intestinal stress damage and the effect of early enteral nutrition on gastrointestinal function. New techniques, such as ultrasound and the capsule techniques, might help to assess intestinal function beyond the aspiration of gastric residual volumes and the passage of stool. Therapeutic options such as opioid antagonists and the 5-hydroxytryptamine receptor 4 agonist prucalopride might help to restore intestinal function. Summary Gastrointestinal motility disturbances are caused by a myriad of pathological processes. Moreover, bowel integrity is governed by comorbidity, impaired metabolic function and pharmacological interventions in critically ill patients. Restoring gastrointestinal function, therefore, requires a multimodal approach including prophylactic management strategies and the sensible use of substances with inhibitory effects on intestinal motility.
引用
收藏
页码:159 / 164
页数:6
相关论文
共 44 条
  • [2] Lactobacillus farciminis treatment attenuates stress-induced overexpression of Fos protein in spinal and supraspinal sites after colorectal distension in rats
    Ait-Belgnaoui, A.
    Eutamene, H.
    Houdeau, E.
    Bueno, L.
    Fioramonti, J.
    Theodorou, V.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2009, 21 (05) : 585 - 593
  • [3] [Anonymous], 2008, THERAPY, DOI DOI 10.2217/14750708.5.4.531
  • [4] Cell-free supernatants of Escherichia coli Nissle 1917 modulate human colonic motility: evidence from an in vitro organ bath study
    Baer, F.
    Von Koschitzky, H.
    Roblick, U.
    Bruch, H. P.
    Schulze, L.
    Sonnenborn, U.
    Boettner, M.
    Wedel, T.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2009, 21 (05) : 575 - 584
  • [5] Beattie DT, 2009, CLIN MED INSIGHTS-TH, V1, P199
  • [6] Clinical trial:: alvimopan for the management of post-operative ileus after abdominal surgery:: results of an international randomized, double-blind, multicentre, placebo-controlled clinical study
    Buechler, M. W.
    Seiler, C. M.
    Monson, J. R. T.
    Flamant, Y.
    Thompson-Fawcett, M. W.
    Byrne, M. M.
    Mortensen, E. R.
    Altman, J. F. B.
    Williamson, R.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (03) : 312 - 325
  • [7] A placebo-controlled trial of prucalopride for severe chronic constipation
    Camilleri, Michael
    Kerstens, Rene
    Rykx, An
    Vandeplassche, Lieve
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (22) : 2344 - 2354
  • [8] Integrated upper gastrointestinal response to food intake
    Camilleri, Michael
    [J]. GASTROENTEROLOGY, 2006, 131 (02) : 640 - 658
  • [9] The action of the novel gastrointestinal prokinetic prucalopride on the HERG K+ channel and the common T897 polymorph
    Chapman, Hugh
    Pasternack, Michael
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 554 (2-3) : 98 - 105
  • [10] The Relationship Between Intestinal Microbiota and the Central Nervous System in Normal Gastrointestinal Function and Disease
    Collins, Stephen M.
    Bercik, Premysl
    [J]. GASTROENTEROLOGY, 2009, 136 (06) : 2003 - 2014